PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 21 filers reported holding PHARVARIS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,246,926 | $24,904,000 | 8.01% |
| venBio Partners LLC | 2,296,710 | $17,616,000 | 4.08% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $24,395,000 | 2.91% |
| 5AM Venture Management, LLC | 587,600 | $4,507,000 | 0.86% |
| Cormorant Asset Management, LP | 1,207,500 | $9,262,000 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 746,965 | $5,729,000 | 0.24% |
| Novo Holdings A/S | 610,000 | $4,679,000 | 0.22% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $18,563,000 | 0.22% |
| Foresite Capital Management V, LLC | 34,142 | $262,000 | 0.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,104,552 | $8,472,000 | 0.17% |